SCOPUS 정보 검색 플랫폼

Volumn 7, Issue 4, 2002, Pages 153-157

Long-term survival in phase II trials of gemcitabine plus cisplatin for advanced transitional cell cancer

(8) Stadler, Walter M a Hayden, Annamaria b Von Der Maase, Hans c Roychowdhury, Debasish b Dogliotti, Luigi d Seymour, Lesley g Kaufmann, Donald e Moore, Malcolm f

a UNIVERSITY OF CHICAGO (United States)

b ELI LILLY AND COMPANY (United States)

c AARHUS UNIVERSITY HOSPITAL (Denmark)

d UNIVERSITY OF TURIN (Italy)

e MASSACHUSETTS GENERAL HOSPITAL (United States)

f PRINCESS MARGARET HOSPITAL (Canada)

g Clinical Trials Group (Canada)

Author keywords

Bladder neoplasms; Combination drug therapy; Transitional cell carcinoma; Treatment outcome prognosis

Indexed keywords

CISPLATIN; GEMCITABINE; ANTINEOPLASTIC AGENT; DEOXYCYTIDINE; DRUG DERIVATIVE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; SIDE EFFECT; SURVIVAL RATE; TRANSITIONAL CELL CARCINOMA; MODEL; SURVIVAL; TREATMENT OUTCOME; UROGENITAL TRACT TUMOR; BLADDER TUMOR; CANCER STAGING; FOLLOW UP; MORTALITY; MULTICENTER STUDY; PATHOLOGY; PHASE 2 CLINICAL TRIAL; PROPORTIONAL HAZARDS MODEL; TIME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLADDER NEOPLASMS; CARCINOMA, TRANSITIONAL CELL; CISPLATIN; DEOXYCYTIDINE; FOLLOW-UP STUDIES; HUMAN; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SUPPORT, NON-U.S. GOV'T; SURVIVAL ANALYSIS; TIME FACTORS; HUMANS; URINARY BLADDER NEOPLASMS;

EID: 0035986528 PISSN: 10781439 EISSN: None Source Type: Journal
DOI: 10.1016/S1078-1439(02)00182-5 Document Type: Article

Times cited : (59)

References (17)

1
- 0023857065
- M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium
- (1988) J Urol , vol.139 , pp. 461-469
- Sternberg, C.N.¹ Yagoda, A.² Scher, H.I.³ Watson, R.C.⁴ Herr, H.W.⁵ Morse, M.J.⁶

2
- 0025297496
- A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors
- (1990) J Clin Oncol , vol.8 , pp. 1050-1055
- Logothetis, C.J.¹ Dexeus, F.H.² Finn, L.³ Sella, A.⁴ Amato, R.J.⁵ Ayala, A.G.⁶ Kilbourn, R.G.⁷

3
- 0026625220
- A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma; a cooperative group study
- (1992) J Clin Oncol , vol.10 , pp. 1066-1073
- Loehrer P.J. Sr¹ Einhorn, L.H.² Elson, P.J.³ Crawford, E.D.⁴ Kuebler, P.⁵ Tannock, I.⁶

4
- 0031005761
- Phase II trial of docetaxel in patients with advanced or metastatic transitional-cell carcinoma
- (1997) J Clin Oncol , vol.15 , pp. 1853-1857
- McCaffrey, J.A.¹ Hilton, S.² Mazumdar, M.³ Sadan, S.⁴ Kelly, W.K.⁵ Scher, H.I.⁶ Bajorin, D.F.⁷

5
- 0030698628
- Phase II study of single-agent gemcitabine in previously untreated patients with metastatic urothelial cancer
- (1997) J Clin Oncol , vol.15 , pp. 3394-3398
- Stadler, W.M.¹ Kuzel, T.² Roth, B.³ Raghavan, D.⁴ Dorr, F.A.⁵

6
- 0027999651
- Significant activity of paclitaxel in advanced transitional-cell carcinoma of the urothelium; a phase II trial of the Eastern Cooperative Oncology Group
- (1994) J Clin Oncol , vol.12 , pp. 2264-2270
- Roth, B.J.¹ Dreicer, R.² Einhorn, L.H.³ Neuberg, D.⁴ Johnson, D.H.⁵ Smith, J.L.⁶

7
- 0034030632
- Gemcitabine in locally advanced and/or metastatic bladder cancer
- (2000) Crit Rev Oncol Hematol , vol.34 , pp. 175-183
- von der Maase, H.¹

8
- 0033859985
- Progress in the management of metastatic bladder cancer
- (2000) Cancer Control , vol.7 , pp. 347-356
- Parimoo, D.¹ Raghavan, D.²

9
- 0033857218
- Gemcitabine and cisplatin vs. methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer; results of a large, randomized, multinational, multicenter, phase III study
- (2000) J Clin Oncol , vol.18 , pp. 3068-3077
- von der Maase, H.¹ Hansen, S.W.² Roberts, J.T.³ Dogliotti, L.⁴ Oliver, T.⁵ Moore, M.J.⁶

10
- 0009812423
- Simon R. New methods for the design and analysis of clinical trials. In: Devita VT, Hellman S., Rosenberg S, editors. Cancer: principles and practice of oncology; PPO Updates, vol. 13, 6. Cedar Knolls, NJ: Lippincott Williams & Wilkins, 1999. p. 1-9.

11
- 17444437833
- Phase II trial of gemcitabine plus cisplatin in patients with metastatic urothelial cancer
- (2000) J Clin Oncol , vol.18 , pp. 1921-1927
- Kaufman, D.¹ Raghavan, D.² Carducci, M.³ Levine, E.G.⁴ Murphy, B.⁵ Aisner, J.⁶

12
- 0032858246
- Gemcitabine plus cisplatin, an active regimen in advanced urothelial cancer; a phase II trial of the National Cancer Institute of Canada Clinical Trials Group
- (1999) J Clin Oncol , vol.17 , pp. 2876-2881
- Moore, M.J.¹ Winquist, E.W.² Murray, N.³ Tannock, I.F.⁴ Huan, S.⁵ Bennett, K.⁶

13
- 0033390548
- Weekly gemcitabine and cisplatin combination therapy in patients with transitional cell carcinoma of the urothelium; a phase II clinical trial
- (1999) Ann Oncol , vol.10 , pp. 1461-1465
- von der Maase, H.¹ Andersen, L.² Crino, L.³ Weinknecht, S.⁴ Dogliotti, L.⁵

14
- 0032887956
- Long-term survival in metastatic transitional-cell carcinoma and prognostic factors predicting outcome of therapy
- (1999) J Clin Oncol , vol.17 , pp. 3173-3181
- Bajorin, D.F.¹ Dodd, P.M.² Mazumdar, M.³ Fazzari, M.⁴ McCaffrey, J.A.⁵ Scher, H.I.⁶

15
- 33845382806
- Nonparametric estimation from incomplete observations
- (1958) J Am Stat Assoc , vol.53 , pp. 457-481
- Kaplan, E.¹ Meier, P.²

16
- 0033747013
- Predictive factors of response to cisplatin-based chemotherapy and the relation of response to survival in patients with metastatic urothelial cancer
- (2000) Cancer Chemother Pharmacol , vol.46 , pp. 357-364
- Sengelov, L.¹ Kamby, C.² Geertsen, P.³ Andersen, L.J.⁴ von der Maase, H.⁵

17
- 0032795983
- Outcome of postchemotherapy surgery after treatment with methotrexate, vinblastine, doxorubicin, and cisplatin in patients with unresectable or metastatic transitional cell carcinoma
- (1999) J Clin Oncol , vol.17 , pp. 2546-2552
- Dodd, P.M.¹ McCaffrey, J.A.² Herr, H.³ Mazumdar, M.⁴ Bacik, J.⁵ Higgins, G.⁶ Boyle, M.G.⁷ Scher, H.I.⁸ Bajorin, D.F.⁹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.